Rentokil Initial PLC's shares fell 19.5% after its first-half results showed better-than-expected profits but revealed slowing growth in its key North American pest-control segment. Adjusted pre-tax profit beat consensus by 4%, and operating margins exceeded forecasts, yet growth in North America slowed from 2.8% to 2.4%. The company also noted some weakness in residential customer leads, raising concerns about the second half. New CEO Mike Duffy has paused margin targets to reinvest savings into sales growth. Analysts remain mixed, with Jefferies cautious but maintaining a buy rating, while Stifel holds a neutral stance, expecting full-year profits to meet forecasts.
Frank Patton and Kimberlee Mott, financial advisors with 45 years of combined experience managing about $150 million in assets, have joined Balmville Wealth Group through LPL Financial. They bring a focus on retirement planning and multigenerational ...
Crescent Biopharma announced its second quarter 2026 financial results, highlighting progress in clinical trials for its cancer therapies, including CR-001, a PD-1 x VEGF bispecific antibody, and ADC candidates CR-002 and CR-003. The company is enrol...
Ferrari reported Q2 2026 net revenues of €1.94 billion, up 8% year-on-year, driven by a richer product mix and increased personalization sales. Operating profit rose 10% to €605 million with a margin of 31.2%, while net profit grew 9% to €463 million...
XRP is trading around $1.07 as positive regulatory developments in Hong Kong and the EU support its outlook, including retail trading launch in Hong Kong and EU MiCA authorization. However, ongoing U.S. regulatory uncertainty due to the SEC's appeal ...
The Federal Trade Commission (FTC) is suing healthcare company Hims & Hers for allegedly sharing customers' sensitive medical data with advertisers and tech giants like Meta and Snap without consent. The FTC claims Hims & Hers used pixel trackers to ...
